Clinical Epidemiology and Ageing

Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment.

Picchi H, Mateus C, Chouaid C, Besse B, Marabelle A, Michot JM, Champiat S, Voisin AL, Lambotte O Clin Microbiol Infect. 2018;24(3):216-218.
MeSH terms: Antibodies, Monoclonal; Antineoplastic Agents; CTLA-4 Antigen; Humans; Immunotherapy; Ligands; Neoplasms; Programmed Cell Death 1 Receptor; Recurrence; T-Lymphocytes, Cytotoxic; Tuberculosis
DOI: 10.1016/j.cmi.2017.12.003